Cargando…
Opportunities for strengthening CTSA evaluation
The purpose of the article is to describe the progress of the Clinical and Translational Science Award (CTSA) Program to address the evaluation-related recommendations made by the 2013 Institute of Medicine’s review of the CTSA Program and guidelines published in CTS Journal the same year (Trochim e...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803463/ https://www.ncbi.nlm.nih.gov/pubmed/31660229 http://dx.doi.org/10.1017/cts.2019.387 |
_version_ | 1783460938819567616 |
---|---|
author | Patel, Tanha Rainwater, Julie Trochim, William M. Elworth, Julie T. Scholl, Linda Dave, Gaurav |
author_facet | Patel, Tanha Rainwater, Julie Trochim, William M. Elworth, Julie T. Scholl, Linda Dave, Gaurav |
author_sort | Patel, Tanha |
collection | PubMed |
description | The purpose of the article is to describe the progress of the Clinical and Translational Science Award (CTSA) Program to address the evaluation-related recommendations made by the 2013 Institute of Medicine’s review of the CTSA Program and guidelines published in CTS Journal the same year (Trochim et al., Clinical and Translational Science 2013; 6(4): 303–309). We utilize data from a 2018 national survey of evaluators administered to all 64 CTSA hubs and a content analysis of the role of evaluation in the CTSA Program Funding Opportunity Announcements to document progress. We present four new opportunities for further strengthening CTSA evaluation efforts: (1) continue to build the collaborative evaluation infrastructure at local and national levels; (2) make better use of existing data; (3) strengthen and augment the common metrics initiative; and (4) pursue internal and external opportunities to evaluate the CTSA program at the national level. This article will be of significant interest to the funders of the CTSA Program and the multiple stakeholders in the larger consortium and will promote dialog from the broad range of CTSA stakeholders about further strengthening the CTSA Program’s evaluation. |
format | Online Article Text |
id | pubmed-6803463 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68034632019-10-28 Opportunities for strengthening CTSA evaluation Patel, Tanha Rainwater, Julie Trochim, William M. Elworth, Julie T. Scholl, Linda Dave, Gaurav J Clin Transl Sci Special Communications The purpose of the article is to describe the progress of the Clinical and Translational Science Award (CTSA) Program to address the evaluation-related recommendations made by the 2013 Institute of Medicine’s review of the CTSA Program and guidelines published in CTS Journal the same year (Trochim et al., Clinical and Translational Science 2013; 6(4): 303–309). We utilize data from a 2018 national survey of evaluators administered to all 64 CTSA hubs and a content analysis of the role of evaluation in the CTSA Program Funding Opportunity Announcements to document progress. We present four new opportunities for further strengthening CTSA evaluation efforts: (1) continue to build the collaborative evaluation infrastructure at local and national levels; (2) make better use of existing data; (3) strengthen and augment the common metrics initiative; and (4) pursue internal and external opportunities to evaluate the CTSA program at the national level. This article will be of significant interest to the funders of the CTSA Program and the multiple stakeholders in the larger consortium and will promote dialog from the broad range of CTSA stakeholders about further strengthening the CTSA Program’s evaluation. Cambridge University Press 2019-07-26 /pmc/articles/PMC6803463/ /pubmed/31660229 http://dx.doi.org/10.1017/cts.2019.387 Text en © The Association for Clinical and Translational Science 2019 https://creativecommons.org/licenses/by-ncnd/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-ncnd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work. |
spellingShingle | Special Communications Patel, Tanha Rainwater, Julie Trochim, William M. Elworth, Julie T. Scholl, Linda Dave, Gaurav Opportunities for strengthening CTSA evaluation |
title | Opportunities for strengthening CTSA evaluation |
title_full | Opportunities for strengthening CTSA evaluation |
title_fullStr | Opportunities for strengthening CTSA evaluation |
title_full_unstemmed | Opportunities for strengthening CTSA evaluation |
title_short | Opportunities for strengthening CTSA evaluation |
title_sort | opportunities for strengthening ctsa evaluation |
topic | Special Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803463/ https://www.ncbi.nlm.nih.gov/pubmed/31660229 http://dx.doi.org/10.1017/cts.2019.387 |
work_keys_str_mv | AT pateltanha opportunitiesforstrengtheningctsaevaluation AT rainwaterjulie opportunitiesforstrengtheningctsaevaluation AT trochimwilliamm opportunitiesforstrengtheningctsaevaluation AT elworthjuliet opportunitiesforstrengtheningctsaevaluation AT scholllinda opportunitiesforstrengtheningctsaevaluation AT davegaurav opportunitiesforstrengtheningctsaevaluation |